• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec25
AstraZeneca's Vilumatin Approved in China for ATTRv-PN Treatment
09:22
AstraZeneca's Enhertu Approved for New Indication
08:41
DS-8201 Receives New Indication Approval in China for Previously Treated HR+, HER2-Low Advanced Breast Cancer
05:45
AstraZeneca and JABYO Enter into a License Agreement, Jacada Shares Under Pressure
01:04
Dec24
Gilead Sciences to Acquire Repare Therapeutics' Cancer Treatment Drugs
12:38
Global X Japan Co. Ltd. Significantly Increases Holdings in Gilead Sciences
09:44